JANSSEN BIOTECH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1979-01-01
- Employees
- 10K
- Market Cap
- -
Icotrokinra Shows Promising Phase 3 Results for Plaque Psoriasis Treatment
Phase 3 trials show Icotrokinra significantly improved skin clearance in adults and adolescents with moderate to severe plaque psoriasis.
Johnson & Johnson Seeks Approval for Darzalex in High-Risk Smoldering Multiple Myeloma
Johnson & Johnson has submitted applications to the FDA and EMA for Darzalex Faspro to treat high-risk smoldering multiple myeloma.